A detailed history of Whittier Trust CO transactions in Alkermes Plc. stock. As of the latest transaction made, Whittier Trust CO holds 415 shares of ALKS stock, worth $12,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
415
Previous 415 -0.0%
Holding current value
$12,304
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

SELL
$23.37 - $28.68 $257 - $315
-11 Reduced 2.58%
415 $11,000
Q3 2023

Oct 27, 2023

BUY
$27.17 - $31.97 $298 - $351
11 Added 2.65%
426 $11,000
Q4 2022

Jan 25, 2023

SELL
$21.94 - $26.24 $1,140 - $1,364
-52 Reduced 11.13%
415 $0
Q1 2022

Apr 29, 2022

BUY
$23.07 - $27.99 $1,199 - $1,455
52 Added 12.53%
467 $12,000
Q3 2017

Oct 23, 2017

BUY
$49.16 - $54.45 $20,401 - $22,596
415
415 $21,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.